Basic Information
RNALocate ID: | RLID:11001257 |
RNA Symbol: | hsa-miR-196a-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-196a-5p |
RNA ID: | miRBase:MIMAT0000226 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 25760330 |
Tissue/Cell Line: | Human cervical cancer cell line (HeLa) |
Method: | qRT-PCR |
Condition: | 72 h after transfection of HeLa cells with si18E6/E7|72 h after transfection of HeLa cells with control siRNA (siContr-1) |
Exosomal miRNA levels were normalized to miR-452-5p and miR-183-5p and calculated relative to siContr-1 (log2 display). Dashed lines: 1.5-fold up- or downregulation (log2(1.5) = 0.585). The column color shows regulation in the same (dark grey) or opposite (light grey) direction compared to the small RNA deep sequencing data of the individual miRNAs. Originally published in PLoS Pathog. Honegger A, et al, 2015. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | qRT-PCR analysis of E6/E7-dependent exosomal miRNAs identified by small RNA deep sequencing. Data are collected from Figure 8(E). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001548 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001549 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001550 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001551 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001552 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001553 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11001258 | Exosome | Serum | 18589210 |
RLID:11001259 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001260 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11001261 | Exosome | Brain tissue | 23382797 |
RLID:11001262 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001263 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000037 | Exosome | Colon tissue|Tongue tissue | |
RLID-D:11000305 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-196a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-23970 |
MNDR | hsa-miR-196a-5p | Oral squamous cell carcinoma | MNDR-E-MI-23971 |
MNDR | hsa-miR-196a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-23972 |
MNDR | hsa-miR-196a-5p | Follicular cleaved lymphoma | MNDR-E-MI-23973 |
MNDR | hsa-miR-196a-5p | Lymphoma | MNDR-E-MI-23974 |
MNDR | hsa-miR-196a-5p | Non-hodgkin lymphoma | MNDR-E-MI-23975 |
MNDR | hsa-miR-196a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-23976 |
MNDR | hsa-miR-196a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-23977 |
MNDR | hsa-miR-196a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-23978 |
MNDR | hsa-miR-196a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-23979 |
MNDR | hsa-miR-196a-5p | Breast cancer luminal | MNDR-E-MI-23980 |
MNDR | hsa-miR-196a-5p | Niemann-pick disease type c | MNDR-E-MI-23981 |
MNDR | hsa-miR-196a-5p | Small intestine cancer | MNDR-E-MI-23982 |
MNDR | hsa-miR-196a-5p | Prostate cancer | MNDR-E-MI-23983 |
MNDR | hsa-miR-196a-5p | Chronic lymphocytic leukemia | MNDR-E-MI-23984 |
MNDR | hsa-miR-196a-5p | Gastric cancer | MNDR-E-MI-23985 |
MNDR | hsa-miR-196a-5p | Adrenoleukodystrophy | MNDR-E-MI-23986 |
MNDR | hsa-miR-196a-5p | Intracranial aneurysm | MNDR-E-MI-23987 |
MNDR | hsa-miR-196a-5p | Esophageal carcinoma | MNDR-E-MI-23988 |
MNDR | hsa-miR-196a-5p | Heart disease | MNDR-E-MI-23989 |
MNDR | hsa-miR-196a-5p | Head and neck cancer | MNDR-E-MI-23990 |
MNDR | hsa-miR-196a-5p | Vitiligo | MNDR-E-MI-23991 |
MNDR | hsa-miR-196a-5p | Leukemia | MNDR-E-MI-23992 |
MNDR | hsa-miR-196a-5p | Acute leukemia | MNDR-E-MI-23993 |
MNDR | hsa-miR-196a-5p | Huntington disease | MNDR-E-MI-23994 |
MNDR | hsa-miR-196a-5p | Chorea | MNDR-E-MI-23995 |
MNDR | hsa-miR-196a-5p | Lung cancer | MNDR-E-MI-23996 |
MNDR | hsa-miR-196a-5p | Down syndrome | MNDR-E-MI-23997 |
MNDR | hsa-miR-196a-5p | Parkinson disease | MNDR-E-MI-23998 |
MNDR | hsa-miR-196a-5p | Niemann-pick disease | MNDR-E-MI-23999 |
MNDR | hsa-miR-196a-5p | Breast cancer | MNDR-E-MI-24000 |
MNDR | hsa-miR-196a-5p | Congenital heart disease | MNDR-E-MI-24001 |
MNDR | hsa-miR-196a-5p | Neuroendocrine neoplasia | MNDR-E-MI-24002 |
MNDR | hsa-miR-196a-5p | Pancreatic cancer | MNDR-E-MI-24003 |
MNDR | hsa-miR-196a-5p | Pancreatic endocrine carcinoma | MNDR-E-MI-24004 |
MNDR | hsa-miR-196a-5p | Malignant melanoma | MNDR-E-MI-24005 |
MNDR | hsa-miR-196a-5p | Rectum adenocarcinoma | MNDR-E-MI-24006 |
MNDR | hsa-miR-196a-5p | Colon cancer | MNDR-E-MI-24007 |
MNDR | hsa-miR-196a-5p | Colon adenocarcinoma | MNDR-E-MI-24008 |
MNDR | hsa-miR-196a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-24009 |
MNDR | hsa-miR-196a-5p | Familial ovarian cancer | MNDR-E-MI-24010 |
MNDR | hsa-miR-196a-5p | Prostate adenocarcinoma | MNDR-E-MI-24011 |
MNDR | hsa-miR-196a-5p | Endometriosis | MNDR-E-MI-24012 |
MNDR | hsa-miR-196a-5p | Pulmonary tuberculosis | MNDR-E-MI-24013 |
MNDR | hsa-miR-196a-5p | Carcinoma ductal breast | MNDR-E-MI-24014 |
MNDR | hsa-miR-196a-5p | Glioblastoma | MNDR-E-MI-24015 |
MNDR | hsa-miR-196a-5p | Glioma | MNDR-E-MI-24016 |
MNDR | hsa-miR-196a-5p | Osteosarcoma | MNDR-E-MI-24017 |
MNDR | hsa-miR-196a-5p | Breast carcinoma | MNDR-E-MI-24018 |
MNDR | hsa-miR-196a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24019 |
MNDR | hsa-miR-196a-5p | Uterus cancer | MNDR-E-MI-24020 |
MNDR | hsa-miR-196a-5p | Gastric adenocarcinoma | MNDR-E-MI-24021 |
MNDR | hsa-miR-196a-5p | Pituitary adenoma | MNDR-E-MI-24022 |
MNDR | hsa-miR-196a-5p | Lung squamous cell carcinoma | MNDR-E-MI-24023 |
MNDR | hsa-miR-196a-5p | Non-small cell lung cancer | MNDR-E-MI-24024 |
MNDR | hsa-miR-196a-5p | Lung adenocarcinoma | MNDR-E-MI-24025 |
MNDR | hsa-miR-196a-5p | Adrenocortical carcinoma | MNDR-E-MI-24026 |
MNDR | hsa-miR-196a-5p | Thyroid carcinoma | MNDR-E-MI-24027 |
MNDR | hsa-miR-196a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-24028 |
MNDR | hsa-miR-196a-5p | Scleroderma | MNDR-E-MI-24029 |
MNDR | hsa-miR-196a-5p | Carcinoma renal cell | MNDR-E-MI-24030 |
MNDR | hsa-miR-196a-5p | Renal clear cell carcinoma | MNDR-E-MI-24031 |
MNDR | hsa-miR-196a-5p | Biliary tract cancer | MNDR-E-MI-24032 |
MNDR | hsa-miR-196a-5p | Esophageal adenocarcinoma | MNDR-E-MI-24033 |
MNDR | hsa-miR-196a-5p | Cholangiocarcinoma | MNDR-E-MI-24034 |
MNDR | hsa-miR-196a-5p | Esophageal cancer | MNDR-E-MI-24035 |
MNDR | hsa-miR-196a-5p | Infertility | MNDR-E-MI-24036 |
MNDR | hsa-miR-196a-5p | Lung small cell carcinoma | MNDR-E-MI-24037 |
MNDR | hsa-miR-196a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-24038 |
MNDR | hsa-miR-196a-5p | Testicular germ cell cancer | MNDR-E-MI-24039 |
MNDR | hsa-miR-196a-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-24040 |
MNDR | hsa-miR-196a-5p | Breast invasive carcinoma | MNDR-E-MI-24041 |
MNDR | hsa-miR-196a-5p | Hepatocellular carcinoma | MNDR-E-MI-24042 |
MNDR | hsa-miR-196a-5p | Embryonal cancer | MNDR-E-MI-24043 |
MNDR | hsa-miR-196a-5p | Familiar ovarian carcinoma | MNDR-E-MI-24044 |
MNDR | hsa-miR-196a-5p | B-cell lymphoma | MNDR-E-MI-24045 |
MNDR | hsa-miR-196a-5p | Retinoblastoma | MNDR-E-MI-24046 |
MNDR | hsa-miR-196a-5p | Barrett's adenocarcinoma | MNDR-E-MI-24047 |
MNDR | hsa-miR-196a-5p | Hodgkin lymphoma | MNDR-E-MI-24048 |
MNDR | hsa-miR-196a-5p | Mouth neoplasms | MNDR-E-MI-24049 |
MNDR | hsa-miR-196a-5p | Crohn disease | MNDR-E-MI-24050 |
MNDR | hsa-miR-196a-5p | Tonsil cancer | MNDR-E-MI-24051 |
MNDR | hsa-miR-196a-5p | Neuromyelitis optica | MNDR-E-MI-24052 |
MNDR | hsa-miR-196a-5p | Gastrointestinal stromal tumor | MNDR-E-MI-24053 |
MNDR | hsa-miR-196a-5p | Colorectal cancer | MNDR-E-MI-24054 |
MNDR | hsa-miR-196a-5p | Type 2 diabetes mellitus | MNDR-E-MI-24055 |
MNDR | hsa-miR-196a-5p | Multiple myeloma | MNDR-E-MI-24056 |
MNDR | hsa-miR-196a-5p | Ependymoma | MNDR-E-MI-24057 |
MNDR | hsa-miR-196a-5p | Prostatic neoplasms | MNDR-E-MI-24058 |
MNDR | hsa-miR-196a-5p | Hypersomnolence idiopathic | MNDR-E-MI-24059 |
MNDR | hsa-miR-196a-5p | Stroke | MNDR-E-MI-24060 |
MNDR | hsa-miR-196a-5p | Stroke lacunar | MNDR-E-MI-24061 |
MNDR | hsa-miR-196a-5p | Barrett's carcinogenesis | MNDR-E-MI-24062 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ANXA1 | Homo sapiens | RR00084307 |
TOP